Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-23.04%
↓ 137% below average
Average (30q)
62.41%
Historical baseline
Range
High:2460.58%
Low:-188.15%
Volatility
4243.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -23.04% |
| Q2 2025 | 33.84% |
| Q1 2025 | 9.51% |
| Q4 2024 | -9.12% |
| Q3 2024 | -102.36% |
| Q2 2024 | 2460.58% |
| Q1 2024 | 15.91% |
| Q4 2023 | -80.74% |
| Q3 2023 | -10.07% |
| Q2 2023 | 3.37% |
| Q1 2023 | -19.01% |
| Q4 2022 | -0.66% |
| Q3 2022 | -7.73% |
| Q2 2022 | -12.66% |
| Q1 2022 | -58.06% |
| Q4 2021 | -2.96% |
| Q3 2021 | 0.63% |
| Q2 2021 | -7.37% |
| Q1 2021 | -9.29% |
| Q4 2020 | 13.89% |
| Q3 2020 | -14.60% |
| Q2 2020 | 10.99% |
| Q1 2020 | -23.23% |
| Q4 2019 | 19.13% |
| Q3 2019 | -81.89% |
| Q2 2019 | -188.15% |
| Q1 2019 | 12.79% |
| Q4 2018 | 0.00% |
| Q2 2018 | 23.51% |
| Q1 2018 | -18.43% |
| Q4 2017 | 0.00% |